Skip to main content

BBC3 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon2 and 1 bp insertion in exon2 and 22 bp deletion in exon2.

Be the first to review this product! Submit a review

Images

Western blot - Human BBC3 (PUMA) knockout HeLa cell lysate (AB256848), expandable thumbnail
  • Sanger Sequencing - Human BBC3 (PUMA) knockout HeLa cell lysate (AB256848), expandable thumbnail
  • Sanger Sequencing - Human BBC3 (PUMA) knockout HeLa cell lysate (AB256848), expandable thumbnail
  • Sanger Sequencing - Human BBC3 (PUMA) knockout HeLa cell lysate (AB256848), expandable thumbnail

Key facts

Cell type
HeLa
Species or organism
Human
Tissue
Cervix
Knockout validation
Sanger Sequencing, Western blot
Mutation description
Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon2 and 1 bp insertion in exon2 and 22 bp deletion in exon2.

Alternative names

What's included?

1 Kit
Components
Human BBC3 knockout HeLa cell lysate
1 x 100 µg
Human wild-type HeLa cell lysate
1 x 100 µg

Recommended products

BBC3 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon2 and 1 bp insertion in exon2 and 22 bp deletion in exon2.

Key facts

Cell type
HeLa
Mutation description
Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon2 and 1 bp insertion in exon2 and 22 bp deletion in exon2.
Disease
Adenocarcinoma
Concentration
Loading...

Properties

Gene name
BBC3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Notes


Knockout cell lysate achieved by CRISPR/Cas9.

Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

PUMA also known as BBC3 (Bcl-2-binding component-3) is a pro-apoptotic protein that plays important mechanical roles in promoting apoptosis. It has a mass of approximately 23 kDa. PUMA is expressed widely in various tissues including the lung liver and heart. The protein works mechanically by interacting with anti-apoptotic Bcl-2 family members releasing pro-apoptotic factors like Bax and Bak which engage mitochondria to trigger cell death.

Biological function summary

PUMA functions as a pivotal mediator of apoptosis in response to diverse stimuli such as DNA damage and oncogenic stress. As part of the Bcl-2 family PUMA does not typically form a complex with other proteins but functions directly by binding and neutralizing anti-apoptotic Bcl-2 family proteins. This action results in the release of caspase-activating factors from mitochondria essential for programmed cell death.

Pathways

Several cellular pathways incorporate PUMA to regulate apoptosis. PUMA is notably included in the p53 pathway where p53 transcriptionally activates PUMA following cellular stress or DNA damage. The presence of related proteins like Bax and Bim in the mitochondrial apoptotic pathway links these signals to the mitochondrial death machinery facilitating apoptosis.

Associated diseases and disorders

PUMA plays significant roles in cancer and neurodegenerative conditions. PUMA overexpression induces excessive cell death relevant in the pathology of neurodegenerative diseases. In cancer PUMA's interactions with proteins like p53 highlight its involvement in tumor suppression suggesting that dysregulation of PUMA expression can contribute to tumorigenesis when anti-apoptotic signals predominate potentially leading to chemoresistance.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

4 product images

  • Western blot - Human BBC3 (PUMA) knockout HeLa cell lysate (ab256848), expandable thumbnail

    Western blot - Human BBC3 (PUMA) knockout HeLa cell lysate (ab256848)

    Lane 1: Wild-type HeLa cell lysate 20 ug
    Lane 2: BBC3 knockout HeLa cell lysate 20 ug
    Lane 3: A549 cell lysate 20 ug
    Lane 4: PC-3 cell lysate 20 ug
    Lanes 1 - 4:Merged signal (red and green). Green - anti-Puma antibody observed at 25 kDa. Red - loading control Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55kDa.
    anti-Puma antibody was shown to react with Puma in wild-type HeLa cells in Western blot with loss of signal observed in BBC3 knockout cell line Human BBC3 (PUMA) knockout HeLa cell line ab261832 (BBC3 knockout cell lysate ab256848). Wild-type HeLa and BBC3 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with anti-Puma antibody and Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

    All lanes: Anti-Puma antibody at 1/1000 dilution

    Lane 1: Wild-type HeLa cell lysate at 20 µg

    Lane 2: BBC3 knockout HeLa cell lysate at 20 µg

    Lane 2: Western blot - Human BBC3 (PUMA) knockout HeLa cell line (Human BBC3 (PUMA) knockout HeLa cell line ab261832)

    Lane 3: A549 cell lysate at 20 µg

    Lane 4: PC-3 cell lysate at 20 µg

    Performed under reducing conditions.

  • Sanger Sequencing - Human BBC3 (PUMA) knockout HeLa cell lysate (ab256848), expandable thumbnail

    Sanger Sequencing - Human BBC3 (PUMA) knockout HeLa cell lysate (ab256848)

    Allele-2: 10 bp deletion in exon2

  • Sanger Sequencing - Human BBC3 (PUMA) knockout HeLa cell lysate (ab256848), expandable thumbnail

    Sanger Sequencing - Human BBC3 (PUMA) knockout HeLa cell lysate (ab256848)

    Allele-1: 22 bp deletion in exon2

  • Sanger Sequencing - Human BBC3 (PUMA) knockout HeLa cell lysate (ab256848), expandable thumbnail

    Sanger Sequencing - Human BBC3 (PUMA) knockout HeLa cell lysate (ab256848)

    Allele-3: 1 bp insertion in exon2

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com